According to our results, we suggest that TNFSF15 gene expression might be altered in pulmonary endothelial cells in patients with ACS, and this may lead to the activation of other proinflammatory cytokines, which causes clinical symptoms of SCD. This evidence concerns the gene TNFSF15 and acute chest syndrome.